Short-Course SBRT: Standard of Care in Prostate Cancer?
For patients with low and favorable intermediate-risk prostate cancer, stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam radiation.
Medscape Medical News
source https://www.medscape.com/viewarticle/997078?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/997078?src=rss
Comments
Post a Comment